|
PFDN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20739999612363E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91060000043208E-07 |
| Normal-vs-Stage2 |
9.556100E-04 |
| Normal-vs-Stage3 |
5.380300E-04 |
| Normal-vs-Stage4 |
3.3664999999905E-06 |
| Stage1-vs-Stage2 |
6.909600E-01 |
| Stage1-vs-Stage3 |
3.788400E-01 |
| Stage1-vs-Stage4 |
1.625840E-01 |
| Stage2-vs-Stage3 |
3.594600E-01 |
| Stage2-vs-Stage4 |
5.003000E-01 |
| Stage3-vs-Stage4 |
6.119900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.95119997515559E-09 |
| Normal-vs-AfricanAmerican |
8.115400E-03 |
| Normal-vs-Asian |
6.612000E-01 |
| Caucasian-vs-AfricanAmerican |
3.380400E-01 |
| Caucasian-vs-Asian |
6.602400E-02 |
| AfricanAmerican-vs-Asian |
1.479250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.94189999822714E-08 |
| Normal-vs-Female |
5.36409999973841E-07 |
| Male-vs-Female |
8.718000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.078300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.7850000000319E-07 |
| Normal-vs-Age(61-80Yrs) |
3.78050000005015E-06 |
| Normal-vs-Age(81-100Yrs) |
5.120600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.559800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.891600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.384400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.836800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.540450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.098220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.400600E-04 |
| Normal-vs-Grade 2 |
3.58540000022778E-07 |
| Normal-vs-Grade 3 |
2.06779999789575E-08 |
| Normal-vs-Grade 4 |
8.384600E-03 |
| Grade 1-vs-Grade 2 |
3.269400E-01 |
| Grade 1-vs-Grade 3 |
8.506200E-01 |
| Grade 1-vs-Grade 4 |
1.442840E-01 |
| Grade 2-vs-Grade 3 |
1.986390E-01 |
| Grade 2-vs-Grade 4 |
3.143200E-01 |
| Grade 3-vs-Grade 4 |
9.344000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.14630527292547E-11 |
| Normal-vs-ccB subtype |
2.762000E-02 |
| ccA subtype-vs-ccB subtype |
1.25589999999676E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.69081999999987E-05 |
| Normal-vs-N1 |
1.046020E-01 |
| N0-vs-N1 |
7.727000E-01 |
|
|
